Targeted treatments for pancreatic cancer may help eligible patients live an extra year

Results from 46 patients given treatments that target specific molecular changes in tumour cells suggest that these therapies could help patients with pancreatic cancer whose tumours harbour those changes survive an extra year.
Read More